LOS ANGELES, Jan. 11, 2024 /PRNewswire/ — Major Wall Street banks have poured billions of dollars into AI development, research, and patents without adequate safeguards, according to an investigation by Consumer Watchdog. But California is developing rules in 2024 that, if properly implemented, will address AI and finances. Under the California Consumer Privacy Act (CCPA),… Continue reading Consumer Watchdog Report Shows How Wall Street AI Could Cause a Financial Crisis And How it Can Be Stopped
Tag: Morgan
CHESAPEAKE ENERGY CORPORATION AND SOUTHWESTERN ENERGY TO COMBINE TO ACCELERATE AMERICA’S ENERGY REACH
OKLAHOMA CITY and SPRING, Texas, Jan. 11, 2024 /PRNewswire/ — Chesapeake Energy Corporation (NASDAQ: CHK) and Southwestern Energy Company (NYSE: SWN) today announced that they have entered into an agreement to merge in an all-stock transaction valued at $7.4 billion, or $6.69 per share, based on Chesapeake’s closing price on January 10, 2024. Under the… Continue reading CHESAPEAKE ENERGY CORPORATION AND SOUTHWESTERN ENERGY TO COMBINE TO ACCELERATE AMERICA’S ENERGY REACH
Thomson Reuters Corporation Announces a Recommended Public Offer to Acquire Pagero – a World Leader in E-Invoicing
TORONTO, Jan. 11, 2024 /PRNewswire/ — Thomson Reuters Corporation (NYSE / TSX: TRI) (“Thomson Reuters”) a global content and technology company, has today announced a recommended public tender offer to acquire 100 per cent of the shares of Pagero Group AB (publ) (Nasdaq First North Growth Market: PAGERO) (“Pagero” or the “Company”) at a price… Continue reading Thomson Reuters Corporation Announces a Recommended Public Offer to Acquire Pagero – a World Leader in E-Invoicing
Ascentage Pharma Presented at 42nd Annual J.P. Morgan Healthcare Conference
SUZHOU, China and ROCKVILLE, Md., Jan. 10, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a commercial stage global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that Dr. Dajun Yang, the company’s Chairman and CEO, gave a speech at the 42nd Annual J.P. Morgan Healthcare Conference.… Continue reading Ascentage Pharma Presented at 42nd Annual J.P. Morgan Healthcare Conference
Celltrion presents strategic vision and growth plan at the 42nd Annual J.P. Morgan Healthcare Conference
Celltrion looks beyond biosimilars to bring value to healthcare and to pioneer innovation Company outlines key business strategies, including expanded product pipeline and healthcare intelligence bank, building upon groundbreaking legacy of success in biosimilars Company highlights its target of 22 products by 2030 and projects five-fold growth INCHEON, South Korea, Jan. 10, 2024 /PRNewswire/ — Celltrion,… Continue reading Celltrion presents strategic vision and growth plan at the 42nd Annual J.P. Morgan Healthcare Conference
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
Strong SOPHiA DDM™ adoption and analysis volume contributes to continued revenue growth Liquid biopsy and HRD on SOPHiA DDM™ Platform continue to grow year-over-year, with Tennessee Oncology, Dasa and The Royal Marsden announced today BOSTON and ROLLE, Switzerland, Jan. 10, 2024 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in… Continue reading SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
HANZA invests in new factory in Sweden
HANZA AB is investing SEK 75 million in an expansion of the Group’s manufacturing cluster in Sweden to meet increasing volumes. KISTA, Sweden, Jan. 10, 2024 /PRNewswire/ — HANZA has decided to build a new factory section of 8,800 square meters in Töcksfors, Sweden. The new facility is a new and extension of HANZA’s existing… Continue reading HANZA invests in new factory in Sweden
Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference
INCHEON, South Korea, Jan. 9, 2024 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business plans and strategy at the J.P. Morgan Healthcare Conference held in San Francisco, California. During the main track presentation, John Rim, CEO and President of Samsung Biologics, announced that the… Continue reading Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference
LOTTE BIOLOGICS Announces Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024
Richard Lee, CEO of LOTTE BIOLOGICS, delivers a keynote speech at the JPM Healthcare Conference for the second consecutive year Unveils company’s bio plant development plan in Songdo to meet clients’ needs SEOUL, South Korea, Jan. 9, 2024 /PRNewswire/ — LOTTE BIOLOGICS (CEO Richard Lee) announced its participation as a participating presenter on the Asia Pacific &… Continue reading LOTTE BIOLOGICS Announces Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024
BRIXMOR PROPERTY GROUP PRICES OFFERING OF SENIOR NOTES
NEW YORK, Jan. 9, 2024 /PRNewswire/ — Brixmor Property Group Inc. (NYSE: BRX) (“Brixmor” or the “Company”) announced today that its operating partnership, Brixmor Operating Partnership LP (the “Operating Partnership”), priced an offering of $400 million aggregate principal amount of 5.500% Senior Notes due 2034 (the “Notes”). The Notes will be issued at 99.816% of par… Continue reading BRIXMOR PROPERTY GROUP PRICES OFFERING OF SENIOR NOTES